Table 3

Gender distribution of reported condom and contraceptive method use among sexually active HIV-positive patients who do not desire a pregnancy in the next 6 months

Contraceptive methodOverall (n=2542*)
[n (%)]
Female (n=1622)
[n (%)]
Male (n=920)
[n (%)]
p
Dual method686 (27)498 (31)188 (20)<0.0001
Highly effective method only*250 (10)210 (13)40 (4)
Condom only1332 (52)716 (44)616 (67)
No method274 (11)198 (12)76 (8)
Dual method use
 Condom+pill117 (17)67 (13)50 (27)<0.0001
 Condom+injectable381 (56)303 (61)78 (41)
 Condom+LAPM†134 (20)85 (17)49 (26)
 Condom+multiple methods‡54 (8)43 (9)11 (6)
Highly effective method
 Pill57 (23)45 (21)12 (30)0.76
 Injectable133 (53)113 (54)20 (50)
 LAPM†40 (16)34 (16)6 (15)
 Multiple methods‡20 (8)18 (9)2 (5)
Unmet need for dual method1856 (73)1124 (69)732 (80)<0.0001
  • N=3538 excluding those who desired a pregnancy (n=565); women aged >49 years (n=63); participants with missing data on contraceptive use (n=268); or missing data on pregnancy desire (n=100).

  • *Highly effective methods included hormonal methods (pill, injectable, implant), intrauterine device or permanent.

  • †LAPM, long-acting or permanent methods (implants, intrauterine device, tubal ligation, vasectomy).

  • ‡Multiple highly effective methods reported.